Frontiers of Medicine in China

, Volume 1, Issue 4, pp 433–437 | Cite as

Effect of oxytocin on gastric ischemia-reperfusion injury in rats

  • Zhang Wenwen 
  • Zhang Jianfu 
  • Xu Ming 
  • Zhang Yongmei 
Research Article
First Online:

Abstract

The effect of peripherally administered oxytocin (OT) on gastric ischemia-reperfusion injury (GI-RI) and its possible mechanism were investigated. The Sprague-Dawley (SD) rats were randomly divided into different treatment groups (n = 6). The animal GI-RI model was established by clamping the celiac artery for 30 min to induce ischemia and then released to allow reperfusion for 1 h, and the degree of GI-RI was assessed by scoring the gastric mucosal damage index (GMDI), the gastric fluid output, gastric fluid output, gastric acidity were measured and the surgical preparations of vagotomy and sympathectomy were used to investigate the possible mechanism of OT on GI-RI. The results were as follows. Compared with the control group (NS plus GI-R only, GMDI 121.33 ± 10.40, n = 6), the intraperitoneal (ip) administration of oxytocin (20, 100 μg/0.5 mL) obviously attenuated GI-RI (P < 0.05), GMDI were 82.33 ± 14.26, 53.5 ± 5.58 respectively (n = 6); the gastric fluid output and the gastric acidity (evaluated by pH) of the control group were (430.17 ± 87.36) μL, 1.55 ± 0.25 (n = 6), and those of the OT group were (102.45 ± 48.00) μL, 2.65 ± 0.40 (n = 6) respectively; differences had statistical significance (P < 0.01). The effect of oxytocin was reversed by atosiban, a selective oxytocin receptor antagonist. The GMDI of the group given atosiban 10 min before OT was 138.17 ± 24.06 (n = 6), which had no significant difference with the control group. Oxytocin further attenuated GI-RI after vagotomy and sympathectomy (GMDI 6.83 ± 8.89, 29.67 ± 5.54, n = 6), compared with the GI-R group and the oxytocin group (P < 0.01). These results indicated that the oxytocin could significantly protect gastric mucosal against injury induced by ischemia-reperfusion, and the oxytocin receptor was involved. This effect of oxytocin may be mediated through the vagus and sympathetic nerve, and then lead to the reduction of gastric juice output and the depression of gastric acidity.

Keywords

oxytocin ischemia reperfusion injury gastric mucosal damage index vagotomy sympathectomy 
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Swanson L W, Sawchenko P E. Hypothalamic integration: Organisation of the paraventricular and supraoptic nuclei. Annu Rev Neurosci, 1983, 6: 269–324PubMedCrossRefGoogle Scholar
  2. 2.
    Uvnas-Moberg K. Antistress pattern induced by oxytocin. News Physiol Sci, 1998, 13: 22–25PubMedGoogle Scholar
  3. 3.
    Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev, 2001, 81(2): 629–683PubMedGoogle Scholar
  4. 4.
    Miranda-Cardenas Y, Rojas-Piloni G, Martinez-Lorenzana G, Rodriguez-Jimenez J, Lopez-Hidalgo M, Freund-Mercier M J, Condes-Lara M. Oxytocin and electrical stimulation of the paraventricular hypothalamic nucleus produce antinociceptive effects that are reversed by an oxytocin antagonist. Pain, 2006, 122(1–2): 182–189PubMedCrossRefGoogle Scholar
  5. 5.
    McEwen B B. General introduction to vasopressin and oxytocin: Structure/metabolism, evolutionary aspects, neural pathway/receptor distribution, and functional aspects relevant to memory processing. Adv Pharmacol, 2004, 50: 1–50, 655–708PubMedCrossRefGoogle Scholar
  6. 6.
    Shojo H, Kaneko Y. Characterization and expression of oxytocin and the oxytocin receptor. Mol Genet Metab, 2000, 71(4): 552–558PubMedCrossRefGoogle Scholar
  7. 7.
    Ohtake M, Sakaguchi T. Inhibition of gastric acid secretion evoked by activation of the hypothalamic paraventricular nucleus. Exp Brain Res, 1987, 66(1): 222–224PubMedCrossRefGoogle Scholar
  8. 8.
    Katoh H, Ohtake M, Sakaguchi T. Secretion of gastric acid inhibited by oxytocin injected into the hypothalamic paraventricular nucleus in the rat. Neuropeptides, 1991, 20(3): 169–173PubMedCrossRefGoogle Scholar
  9. 9.
    Asad M, Shewade D G, Koumaravelou K, Abraham B K, Vasu S, Ramaswamy S. Effect of centrally administered oxytocin on gastric and duodenal ulcers in rats. Acta Pharmacol Sin, 2001, 22(6): 488–492PubMedGoogle Scholar
  10. 10.
    Asad M, Shewade D G, Koumaravelou K, Abraham B K, Vasu S, Ramaswamy S. Gastric antisecretory and antiulcer activity of oxytocin in rats and guinea pigs. Life Sci, 2001, 70(1): 17–24PubMedCrossRefGoogle Scholar
  11. 11.
    Petersson M, Hulting A, Andersson R, Uvnas-Moberg K. Long term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment. Neuroendocrinology, 1999, 69(3): 202–208PubMedCrossRefGoogle Scholar
  12. 12.
    Rogers R C, Hermann G E. Dorsal medullary oxytocin, vasopressin, oxytocin antagonist and TRH effects on gastric acid secretion and heart rate. Peptides, 1985, 6(6): 1143–1148PubMedCrossRefGoogle Scholar
  13. 13.
    Homer-Vanniasinkam S, Crinnion J N, Gough M J. Post-ischemic organ dysfunction: A review. Eur J Vasc Endovasc Surg, 1997, 14(3): 195–203PubMedCrossRefGoogle Scholar
  14. 14.
    Jean-Claude J M, Reilly L M, Stoney R J, Messina L M. Pararenal aortic aneurysms: The future of open aortic aneurysm repair. J Vasc Surg, 1999, 29(5): 902–912PubMedCrossRefGoogle Scholar
  15. 15.
    Wada K, Montalto M C, Stahl G L. Inhibition of complement C5 reduces local and remote organ injury after intestinal ischemia/reperfusion in the rat. Gastroenterology, 2001, 120(1):126–133PubMedCrossRefGoogle Scholar
  16. 16.
    Mythen M G, Webb A R. Intra-operative gut mucosal hypoperfusion is associated with increased post-operative complication and cost. Intensive Care Med, 1994, 20(2): 99–104PubMedCrossRefGoogle Scholar
  17. 17.
    Swank G M, Deitch E A. Role of the gut in multiple organ failure: Bacterial translocation and permeability changes. World J Surg, 1996, 20(4): 411–417PubMedCrossRefGoogle Scholar
  18. 18.
    De La Lastra C A, Cabeza J, Motilva V, Martin M J. Melatonin protects against gastric ischemia-reperfusion injury in rats. J Pineal Res, 1997, 23(2): 47–52CrossRefGoogle Scholar
  19. 19.
    Kishimoto Y, Wada K, Nakamoto K, Ashida K, Kamisaki Y, Kawasaki H, Itoh T. Quantitative analysis of cyclooxygenase-2 gene expression on acute gastric injury induced by ischemia-reperfusion in rats. Life Sci, 1997, 60(8): PL127–133PubMedCrossRefGoogle Scholar
  20. 20.
    Kitano M, Wada K, Kamisaki Y, Nakamoto K, Kishimoto Y, Kawasaki H, Itoh T. Effects of cimetidine on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Pharmacology, 1997, 55(3): 154–164PubMedCrossRefGoogle Scholar
  21. 21.
    Wada K, Kamisaki Y, Kitano M, Nakamoto K, Itoh T. Protective effect of cystathionine on acute gastric mucosal injury induced by ischemia-reperfusion in rats. Eur J Pharmacol, 1995, 294(2–3): 377–382PubMedCrossRefGoogle Scholar
  22. 22.
    Wada K, Kamisaki Y, Kitano M, Kishimoto Y, Nakamoto K, Itoh T. A new gastric ulcer model induced by ischemia-reperfusion in the rat: Role of leukocytes on ulceration in rat stomach. Life Sci, 1996, 59(19): PL295–301PubMedCrossRefGoogle Scholar
  23. 23.
    Guth P H, Aures D, Pauslsen G. Topical aspirin plus HCl gastric lesion in the rat. Gastroenterology, 1979, 76(1): 88–93PubMedGoogle Scholar
  24. 24.
    Mordes J P, el Lozy M G, Herrera M G, Silen W. Effects of vagotomy with and without pyloroplasty on weight and food intake in rat. Am J Physiol, 1979, 236(1): R61–66PubMedGoogle Scholar
  25. 25.
    Alm P, Liedberg G, Owman C. Gastric and pancreatic sympathetic denervation in the rat technique and results. Scand J Gastroent, 1971, 6(4): 307–312PubMedCrossRefGoogle Scholar
  26. 26.
    Hassan M, Kashimura H, Matsumaru K, Nakahara A, Fukutomi H, Muto H, Goto K, Tanaka N. Phosphoramidone, an endothelin converting enzyme inhibitor attenuates local gastric ischemia-reperfusion injury in rats. Life Sci, 1997, 61(10): PL141–147CrossRefGoogle Scholar
  27. 27.
    Ishii M, Shmizu S, Nawata S, Kuuchi Y, Yamamoto T. Involvement of reactive oxygen species and nitric oxide in gastric ischemia-reperfusion injury in rats: Protective effect of tetrahydrobiopterin. Dig Dis Sci, 2000, 45(1): 93–98PubMedCrossRefGoogle Scholar
  28. 28.
    Calatayud S, Quinta E, Esplaques J, Barrachina M D. Role of central oxytocin in the inhibition by endotoxin of distension stimulated acid secretion. Naunyn Schmiedebergs Arch Pharmacol, 1999, 360(6): 676–682PubMedCrossRefGoogle Scholar
  29. 29.
    Duridanova D B, Nedelcheva M D, Gagov H S. Oxytocin induced changes in the single cell K+ currents and smooth muscle contraction of guinea pig antrum. Eur J Pharmacol, 1997, 136(5): 531–538Google Scholar
  30. 30.
    Caltabiano S, Breman F T, Kinter L B. In vitro inhibition of gastric acid secretion by vasopressin. Eur J Pharmacol, 1987, 139(3): 281–286PubMedCrossRefGoogle Scholar
  31. 31.
    Jones P M, Robinson I C. Differential clearance of neurophysin and neurophypophyseal peptides from the cerebrospinal fluid in conscious guinea pigs. Neuroendocrinology, 1982, 34(4): 297–302PubMedCrossRefGoogle Scholar
  32. 32.
    Brinton R C, Wamsley J K, Wan Y P, Yamamura H I. [3H] Oxytocin binding sites in the rat brain demonstrated by quantitative microscopic audiography. Eur J Pharmacol, 1984, 102(2): 365–367PubMedCrossRefGoogle Scholar
  33. 33.
    Zhang Y M, Zhang J F, Yan C D, Qi Y J. Effect of electrostimulation of hypothalamic paraventricular nucleus on gastric ischemia-reperfution injury of rats. Jichu Yixue Yu Linchuang, 2002, 22(3): 264–267 (in Chinese)Google Scholar
  34. 34.
    Zhang J F, Zhang Y M, Yan C D, Zhou X P. Neuroregulative mechanism of hypothalamic paraventricular nucleus on gastric ischemia-reperfusion injury in rats. Life Sci, 2002, 71(13): 1501–1510PubMedCrossRefGoogle Scholar

Copyright information

© Higher Education Press and Springer-Verlag 2007

Authors and Affiliations

  • Zhang Wenwen 
    • 1
    • 2
  • Zhang Jianfu 
    • 1
    • 2
  • Xu Ming 
    • 3
  • Zhang Yongmei 
    • 1
    • 2
  1. 1.Department of PhysiologyXuzhou Medical CollegeXuzhouChina
  2. 2.Department of NeurobiologyXuzhou Medical CollegeXuzhouChina
  3. 3.Department of PathophysiologyXuzhou Medical CollegeXuzhouChina

Personalised recommendations